Cargando…
The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation
Pancreatic ductal adenocarcinoma (PDAC) is the leading cause of cancer-related mortality, primarily due to the abundance of cancer-associated fibroblasts (CAFs), depleted effector T cells, and increased tumor cell stemness; hence, there is an urgent need for efficient biomarkers with prognostic and...
Autores principales: | Liu, Chao, Du, Jiang, Zheng, Jianwei, Zhang, Ruizhe, Zhu, Jialin, Xing, Bofan, Dong, Lin, Zhou, Qianqian, Yao, Xiaofeng, Gao, Song, Wang, Yu, Ren, Yu, Zhou, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291124/ https://www.ncbi.nlm.nih.gov/pubmed/37377917 http://dx.doi.org/10.3389/fonc.2023.1151321 |
Ejemplares similares
-
Bhlhe40: Gatekeeper of the GC
por: Nutt, Stephen L., et al.
Publicado: (2021) -
Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of ADAM19 and KLF7
por: Sui, Yuan, et al.
Publicado: (2023) -
Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
por: Dai, Manxiong, et al.
Publicado: (2022) -
Non-circadian aspects of BHLHE40 cellular function in cancer
por: Kiss, Zsofia, et al.
Publicado: (2020) -
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40
por: Yin, Yongmei, et al.
Publicado: (2023)